204 related articles for article (PubMed ID: 37082201)
1. Pan-cancer analysis of ADAMs: A promising biomarker for prognosis and response to chemotherapy and immunotherapy.
Ma B; Yu R
Front Genet; 2023; 14():1105900. PubMed ID: 37082201
[No Abstract] [Full Text] [Related]
2. Pan-Cancer Analysis of the TRP Family, Especially TRPV4 and TRPC4, and Its Expression Correlated with Prognosis, Tumor Microenvironment, and Treatment Sensitivity.
Chen Z; Zhao Y; Tian Y; Cao R; Shang D
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830651
[TBL] [Abstract][Full Text] [Related]
3. Pan-cancer analyses of clinical prognosis, immune infiltration, and immunotherapy efficacy for TRPV family using multi-omics data.
Shen C; Fu C; Suo Y; Li K; Zhang Z; Yang S; Zhang Y; Lin Y; Li Z; Wu Z; Huang S; Chen H; Fan Z; Hu H
Heliyon; 2023 Jun; 9(6):e16897. PubMed ID: 37346342
[TBL] [Abstract][Full Text] [Related]
4. TMX family genes and their association with prognosis, immune infiltration, and chemotherapy in human pan-cancer.
Luo N; Mei Z; Zhang Q; Tang H; Wan R; Deng A; Zou X; Lv C
Aging (Albany NY); 2023 Dec; 15(24):15064-15083. PubMed ID: 38147024
[TBL] [Abstract][Full Text] [Related]
5. Integrative analysis revealed a correlation of PIAS family genes expression with prognosis, immunomodulation and chemotherapy.
Zhang Q; Zhang J; Lan T; He J; Lei B; Wang H; Mei Z; Lv C
Eur J Med Res; 2024 Mar; 29(1):195. PubMed ID: 38528630
[TBL] [Abstract][Full Text] [Related]
6. Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in colorectal cancer.
Zheng H; Liu H; Li H; Dou W; Wang J; Zhang J; Liu T; Wu Y; Liu Y; Wang X
Stem Cell Res Ther; 2022 Jun; 13(1):244. PubMed ID: 35681225
[TBL] [Abstract][Full Text] [Related]
7. The Pan-Cancer Landscape of Crosstalk Between TRP Family and Tumour Microenvironment Relevant to Prognosis and Immunotherapy Response.
Wu G; He M; Yin X; Wang W; Zhou J; Ren K; Chen X; Xue Q
Front Immunol; 2022; 13():837665. PubMed ID: 35493463
[TBL] [Abstract][Full Text] [Related]
8. FAM3 family genes are associated with prognostic value of human cancer: a pan-cancer analysis.
Dong QT; Ma DD; Gong Q; Lin ZY; Li ZH; Ye JX; Qin CH; Jin WD; Zhang JX; Zhang ZY
Sci Rep; 2023 Sep; 13(1):15144. PubMed ID: 37704682
[TBL] [Abstract][Full Text] [Related]
9. The role of Angiogenesis and remodeling (AR) associated signature for predicting prognosis and clinical outcome of immunotherapy in pan-cancer.
Sun X; Zhang Z; Wang Z; Xie R; Yi C; Liu H; Chi X; Li T; Liu H; Han Y; Pang X; Cui Y; Liu Z
Front Immunol; 2022; 13():1033967. PubMed ID: 36479101
[TBL] [Abstract][Full Text] [Related]
10. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
Front Genet; 2022; 13():919389. PubMed ID: 35783281
[No Abstract] [Full Text] [Related]
11. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature.
Zhou S; Sun Y; Chen T; Wang J; He J; Lyu J; Shen Y; Chen X; Yang R
Front Cell Dev Biol; 2021; 9():739594. PubMed ID: 34660598
[TBL] [Abstract][Full Text] [Related]
12. Pan-cancer analysis identifies proteasome 26S subunit, ATPase (PSMC) family genes, and related signatures associated with prognosis, immune profile, and therapeutic response in lung adenocarcinoma.
Jia H; Tang WJ; Sun L; Wan C; Zhou Y; Shen WZ
Front Genet; 2022; 13():1017866. PubMed ID: 36699466
[No Abstract] [Full Text] [Related]
13. Pan-cancer analysis reveals interleukin-17 family members as biomarkers in the prediction for immune checkpoint inhibitor curative effect.
Han X; Ye J; Huang R; Li Y; Liu J; Meng T; Song D
Front Immunol; 2022; 13():900273. PubMed ID: 36159856
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Bioinformatics Analysis of Toll-Like Receptors (TLRs) in Pan-Cancer.
Ping W; Hong S; Xun Y; Li C
Biomed Res Int; 2022; 2022():4436646. PubMed ID: 35937402
[TBL] [Abstract][Full Text] [Related]
15. A pan-cancer analysis of the HER family gene and their association with prognosis, tumor microenvironment, and therapeutic targets.
Yang X; Miao Y; Wang J; Mi D
Life Sci; 2021 May; 273():119307. PubMed ID: 33691171
[TBL] [Abstract][Full Text] [Related]
16. Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma.
Yao J; Duan L; Huang X; Liu J; Fan X; Xiao Z; Yan R; Liu H; An G; Hu B; Ge Y
Front Oncol; 2021; 11():769727. PubMed ID: 34926275
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Analysis of the Oncogenic, Genomic Alteration, and Immunological Landscape of Cation-Chloride Cotransporters in Pan-Cancer.
Wang J; Liu W; Xu W; Yang B; Cui M; Li Z; Zhang H; Jin C; Xue H; Zhang J
Front Oncol; 2022; 12():819688. PubMed ID: 35372048
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive analysis and validation of cuproptosis-associated genes across cancers: Overall survival, the tumor microenvironment, stemness scores, and drug sensitivity.
Liu J; Lu Y; Dai Y; Shen Y; Zeng C; Liu X; Yu H; Deng J; Lu W
Front Genet; 2022; 13():939956. PubMed ID: 36105090
[No Abstract] [Full Text] [Related]
19. Integrated Analysis of
Du X; Xia W; Fan W; Shen X; Wu H; Zhang H
Dis Markers; 2022; 2022():9365046. PubMed ID: 36118669
[No Abstract] [Full Text] [Related]
20. A pan-cancer landscape of IGF2BPs and their association with prognosis, stemness and tumor immune microenvironment.
Shao W; Zhao H; Zhang S; Ding Q; Guo Y; Hou K; Kan Y; Deng F; Xu Q
Front Oncol; 2022; 12():1049183. PubMed ID: 36686749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
